It's truly impossible for a family or internal medicine

New Post Public Reply Private Reply Replies (2) Message Board
Respert24 Buddyboy20 #150725
868
It's truly impossible for a family or internal medicine doctor to keep fully up to date with all the new research. Most just don't have the bandwidth to work full time and simultaneously fit in a second full time job reading the never-ending new research articles getting published daily.

In fact, in terms of earning their continuing education credits that they're expected to get each year, most will just attend a couple weekend conferences where if they attend classes for a couple days straight they'll earn all they need.

Many don't speak with pharma reps, so they can't get it there. It's one thing to be too busy to make time until it's absolutely necessary, but it's another to be wholly dismissive of something as potentially pertinent to his/her job. That's the main reason I'd find a new doctor, though you list some other excellent reasons. But not having an open mind and admittedly not doing research to enhance his/her knowledge base is a big red flag. Next thing you know you'll be getting subpar treatment as they hold onto drugs that have long since been surpassed by two or three generational leaps forward in efficacy and safety.

An additional reason many doctors will immediately dismiss anything a patient says is because they have plenty of iCraigs they see on a regular basis who come in demanding things after four seconds of googling, like refusing to leave without an antibiotic when the doc knows it's viral but the patient "heard from a friend" otherwise. It's gotta be exhausting.

Before you leave I'd print some things out and leave them with him on your last visit. You could say that you're leaving for the reasons you listed, of course. Or not. But handing a few journal articles to him with "the idea that CCR5 is implicated in more conditions than just HIV isn't just me, a patient, saying it. At the rate research is going, within a few years you might start to see your Mash patients and oncology patients coming back from specialists on drugs that block CCR5. Pulmonary fibrosis and Alzheimer's as well. Might want to bone up."

(But maybe don't be too harsh as he'd probably not read the articles then)

Here's two fast ones I pulled up without digging very deep:

https://aacrjournals.org/cancerres/article/79...er-and-Its

https://www.frontiersin.org/journals/immunolo...01981/full

CytoDyn Inc (CYDY) Stock Research Links

CYDY Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Direct Digital Holdings' Q1 2025 Financial Performance Surges

Updated Category News Views 142

Direct Digital Holdings' Impressive Growth in Q1 2025 In the realm of advertising and marketing technology, Direct Digital Holdings, Inc. (Nasdaq: DRCT) stands out with its recent financial results for the first quarter of 2025. The company, known for its innovative solutions in the advertising space, has showcased remarkable growth in several business segments,...

Continue Reading
Investors Explore Legal Action Against Metagenomi, Inc. for Fraud

Updated Category News Views 184

Opportunity for Investors to Initiate Legal Proceedings Investors with significant losses in their Metagenomi, Inc. holdings may find a potential path to justice through a class action lawsuit. You might be among the shareholders whose trust has been compromised. The company, Metagenomi, Inc. (NASDAQ: MGX), faces allegations of failing to disclose crucial information that...

Continue Reading
Duck Creek Technologies' Annual Summit Emphasizes Inclusion

Updated Category News Views 240

Duck Creek Technologies Hosts the Fourth Annual One Duck Creek India Inclusion Summit In a celebration of diversity and innovation, Duck Creek Technologies is set to host its Fourth Annual One Duck Creek India Inclusion Summit. This flagship event will take place over two days, focusing on fostering a culture of inclusion and community engagement. The summit stands as a...

Continue Reading
Orion Group Releases Strong Half-Year Financial Results

Updated Category News Views 184

Orion Group Financial Report Overview ORION CORPORATION has successfully released its Half-Year Financial Report highlighting impressive growth in its financial metrics for the first half of 2025. This report marks a significant achievement in the company’s performance across major divisions, reflecting a robust strategy aimed at fostering ongoing development and...

Continue Reading
Leadership Changes at Virbac: Insights into Huron's Departure

Updated Category News Views 219

Leadership Transition at Virbac Virbac is experiencing a major leadership change with the resignation of Sébastien Huron as chief executive officer. The board officially recognized this shift during their recent meeting. His departure is effective as of September 27, marking the conclusion of an important chapter for the company. Financial Terms of Resignation In...

Continue Reading